KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427,409 | -97.0% | 46,865 | -95.9% | 0.00% | -97.1% |
| Q1 2023 | $14,016,265 | -50.9% | 1,146,056 | -50.2% | 0.04% | -55.1% |
| Q4 2022 | $28,530,826 | +10.4% | 2,299,019 | +21.5% | 0.08% | -1.3% |
| Q3 2022 | $25,837,000 | -1.7% | 1,891,485 | +31.9% | 0.08% | -8.1% |
| Q2 2022 | $26,285,000 | – | 1,434,014 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |